Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: GROSSMAN JONAS
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Giroux Richard
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Rice Michael Yehuda
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Rossen Matthew
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Barudin Guy
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Kaufman George
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Amusa Gbolahan
-
Form CERT Chardan Healthcare Acqui
-
Form 8-A12B/A Chardan Healthcare Acqui
-
Form 8-A12B Chardan Healthcare Acqui
-
Form S-1/A Chardan Healthcare Acqui
-
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Form S-1/A Chardan Healthcare Acqui
-
Immunovant (IMVT) Announces Pricing of $121.2 Million Public Offering of Common Stock
-
Immunovant Announces Pricing of $121.2 Million Public Offering
-
UPDATE - EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
UPDATE - EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
Chardan Acts as M&A and Capital Markets Advisor in EdtechX Holdings' Completed Merger with Meten Education (China)
-
EdtechX Holdings (NASDAQ:EDTX) and Meten International Announce Successful Merger Closing and Capital Raise
-
EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing
-
BiomX Reports Full Year 2019 Financial Results and Provides Business Update
-
LifeSci Acquisition Corp. Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering
-
Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
-
4D Pharma Presents Additional Interim Clinical Data From Combination Study for Lead Oncology Candidate
-
Seres Therapeutics to Virtually Present at the Chardan Microbiome Medicines Summit
-
Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit
-
LifeSci Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
-
Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual Summit
-
Krystal Biotech (KRYS) PT Raised to $100 at Chardan Capital Markets
-
Kaleido Biosciences to Present During Chardan’s 2nd Annual Microbiome Medicines Summit
-
Kaleido Biosciences to Present During Chardan’s 2nd Annual Microbiome Medicines Summit
-
Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
-
Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
-
Form S-1 Chardan Healthcare Acqui
-
Chardan Capital Markets Starts NeuBase Therapeutics (NBSE) at Buy
-
LifeSci Acquisition Corp (LSAC) Prices 6M Unit IPO at $10/Unit
-
Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy Ahead of HBV Clinical Data
-
LifeSci Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
-
uniQure BV (QURE) PT Lowered to $105 at Chardan Capital Markets
-
uniQure to Participate in Multiple Upcoming Industry Conferences in March
-
uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
Passage Bio (PASG) IPO Opens 24% Higher
-
Passage Bio, Inc. (PASG) Prices 12M Share IPO at $18/Sh
-
Passage Bio Announces Pricing of Initial Public Offering
-
Passage Bio Announces Pricing of Initial Public Offering
-
Update: EdtechX Holdings (NASDAQ: EDTX) : Trading Update From Meten International Education Group
-
EdtechX Holdings (NASDAQ: EDTX) : Trading Update From Meten International Education Group

